Drug Shortage Report for FAMPYRA
Report ID | 173164 |
Drug Identification Number | 02379910 |
Brand name | FAMPYRA |
Common or Proper name | fampridine |
Company Name | BIOGEN CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | FAMPRIDINE |
Strength(s) | 10MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 14 tablets per bottle (x4 Bottles) |
ATC code | N07XX |
ATC description | OTHER NERVOUS SYSTEM DRUGS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2022-11-07 |
Actual start date | |
Estimated end date | 2022-11-17 |
Actual end date | 2022-11-17 |
Shortage status | Resolved |
Updated date | 2022-11-18 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3300 BLOOR STREET WEST, WEST TOWER, SUITE 1200 TORONTO, ONTARIO CANADA M8X 2X2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2022-11-18 | English | Compare |
v8 | 2022-11-17 | French | Compare |
v7 | 2022-11-17 | English | Compare |
v6 | 2022-11-17 | English | Compare |
v5 | 2022-11-11 | French | Compare |
v4 | 2022-11-11 | English | Compare |
v3 | 2022-11-08 | English | Compare |
v2 | 2022-10-31 | French | Compare |
v1 | 2022-10-31 | English | Compare |
Showing 1 to 9 of 9